Cargando…
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic
SIMPLE SUMMARY: Breast cancer is the most common cancer affecting women, and the importance of NR function in breast cancer biology has been recognized since the turn of the 20(th) century. The nuclear receptor family of transcription factors is associated with cancer development and progression, in...
Autores principales: | Kumar, Sanjeev, Freelander, Allegra, Lim, Elgene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507977/ https://www.ncbi.nlm.nih.gov/pubmed/34638457 http://dx.doi.org/10.3390/cancers13194972 |
Ejemplares similares
-
Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer
por: Freelander, Allegra, et al.
Publicado: (2021) -
CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective
por: Zhou, Fiona H., et al.
Publicado: (2023) -
Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
por: Anestis, Aristomenis, et al.
Publicado: (2020) -
Renewed interest in the progesterone receptor in breast cancer
por: Lim, Elgene, et al.
Publicado: (2016) -
MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer
por: Portman, Neil, et al.
Publicado: (2021)